TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11977538

Group type: EXPERIMENTAL
Intervention: Dietary guidance and ingestion of aged garlic extract (AGE) capsules
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dietary guidance and non‐function capsules
Number of subjects: 100
Study: 9846676

Group type: EXPERIMENTAL
Intervention: Transdermal oestrogens 50 microg, 2 patches/week for 3 weeks per month, plus acetate nomegestrolo per os 5 mg/die for 12 days per cycle (Group A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/die (Group B)
Number of subjects: 44

Group type: COMPARATOR
Intervention: No medication (Control Group C)
Number of subjects: 44
Study: 8137201

Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiation therapy (CRT) - 20 Gy and two courses of 5-FU and cisplatin
Number of subjects: 86

Group type: COMPARATOR
Intervention: Surgery (non-CRT)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups (CRT and non-CRT)
Number of subjects: 86
Study: 2589432

Group type: EXPERIMENTAL
Intervention: Lamicel dilators
Number of subjects: 51

Group type: COMPARATOR
Intervention: Dilapan dilators
Number of subjects: 51
Study: 1262709

Group type: EXPERIMENTAL
Intervention: Freshly harvested vaccine (3 x 10(10)‐10(11) organisms/dose)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Lyophilized vaccine
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Fresh vaccine
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 179
Study: 31825893

Group type: EXPERIMENTAL
Intervention: Rehabilitation program with PENS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 16
Study: 31169793

Group type: EXPERIMENTAL
Intervention: Ultrasound (via cloud‐based software measuring pixilation intensity)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HIGH carbohydrate intake (8 g·kg body mass)
Number of subjects: 30

Group type: COMPARATOR
Intervention: LOW carbohydrate intake (3 g·kg body mass)
Number of subjects: 30
Study: 28193568

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 222

Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 222
Study: 25815420

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 683
Study: 23446963

Group type: EXPERIMENTAL
Intervention: Fortified food supplement (SG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No food supplement (NSG)
Number of subjects: 0
Study: 21693443

Group type: EXPERIMENTAL
Intervention: Hyalograft‐3D autograft followed by Laserskin autograft after 2 weeks (treatment group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nonadherent paraffin gauze (control group)
Number of subjects: 180
Study: 18952009

Group type: EXPERIMENTAL
Intervention: Topical l-NAME (NO synthase inhibitor)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Inhalation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study: 17227571

Group type: EXPERIMENTAL
Intervention: Losartan (50-100 mg daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Carvedilol (12.5-25 mg)
Number of subjects: 16
Study: 16083171

Group type: EXPERIMENTAL
Intervention: Continuous ultrasound therapy with intensity of 0.5 W/cm2 applied to the palmar carpal tunnel for 10 minutes, 5 days a week for 4 weeks.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham ultrasound and Diclofenac 75 mg/day in divided doses.
Number of subjects: 18
Study: 11063786

Group type: EXPERIMENTAL
Intervention: SES+SFT
Number of subjects: 30

Group type: COMPARATOR
Intervention: SES
Number of subjects: 30
Study: 9362823

Group type: EXPERIMENTAL
Intervention: Managing Aggressive Behavior program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (did not attend the workshop)
Number of subjects: 0
Study: 1545745

Group type: EXPERIMENTAL
Intervention: Educational campaign for hospital staff and patients, including a booklet and video; duration not specified.
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned but implied as those not exposed to the educational campaign).
Number of subjects: 214
Study: 2418304

Group type: EXPERIMENTAL
Intervention: HOE 498 (2.5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HOE 498 (5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HOE 498 (10 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HOE 498 (20 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HOE 498 (various doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31440980

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 1287

Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 1287
Study: 28094479

Group type: EXPERIMENTAL
Intervention: Retromolar direct laryngoscopy using Miller blade #4
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional direct laryngoscopy using Macintosh blade #3
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: BURP maneuver
Number of subjects: 100
Study: 25636013

Group type: EXPERIMENTAL
Intervention: Visual distraction (Group A)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Audiovisual distraction (Group B)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Routine care (Group C)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Visual distraction (Group A) and Audiovisual distraction (Group B)
Number of subjects: 180
Study: 22824921

Group type: EXPERIMENTAL
Intervention: propofol/fentanyl/dexmedetomidine (PFD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: propofol/fentanyl/placebo-saline (PFS)
Number of subjects: 54
Study: 21448918

Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg plus vitamin D(3) 2800 IU (ALN + D)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 18296901

Group type: EXPERIMENTAL
Intervention: Neolus (Ns)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Yale Spinal (YS)
Number of subjects: 312
Study: 16813472

Group type: EXPERIMENTAL
Intervention: Brisk walking combined with moderate resistance training
Number of subjects: 134

Group type: COMPARATOR
Intervention: Continuous walking
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Fractionated walking (2 daily sessions)
Number of subjects: 134
Study: 12944249

Group type: EXPERIMENTAL
Intervention: Dark chocolate (100 g)
Number of subjects: 30

Group type: COMPARATOR
Intervention: White chocolate (100 g)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Milk chocolate (100 g)
Number of subjects: 30
Study: 10468691

Group type: EXPERIMENTAL
Intervention: Octreotide (100 microg bolus)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8735062

Group type: EXPERIMENTAL
Intervention: Recognition of depression by physicians
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Elevated BDI scores
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Failure to recognize depression
Number of subjects: 508
Study: 1678316

Group type: EXPERIMENTAL
Intervention: Bopindolol (B) 2 mg once daily after initial 1 mg for 4 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Diltiazem (D) 240 mg in 4 divided doses after initial 120 mg
Number of subjects: 31
Study: 7142984

Group type: EXPERIMENTAL
Intervention: Experimental Group received a demonstration of physical and behavioral characteristics of their own infants resulting in a doubling of the usual time for interaction during the first two days.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Hospital Group spent the same amount of time viewing a prepared videotape of the same characteristics of a newborn infant who was not theirs.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Office Control Group, without experimental intervention.
Number of subjects: 48
Study: 30362819

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (8 weeks, 3 sessions/week)
Number of subjects: 28
Study: 27690742

Group type: EXPERIMENTAL
Intervention: CogState
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: CNS‐VS
Number of subjects: 272

Group type: COMPARATOR
Intervention: ANAM4
Number of subjects: 272

Group type: COMPARATOR
Intervention: ImPACT
Number of subjects: 272
Study: 26384091

Group type: EXPERIMENTAL
Intervention: Berberis aristata/Silybum marianum (B. aristata/S. marianum) 588/105 mg, 1 tablet at lunch and 1 tablet at dinner for six months
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Berberis aristata/Silybum marianum (B. aristata/S. marianum)
Number of subjects: 85
Study: 25300245

Group type: EXPERIMENTAL
Intervention: Combined intervention (psychoeducation plus medication)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Treatment-as-usual (medication)
Number of subjects: 61
Study: 22352291

Group type: EXPERIMENTAL
Intervention: Therapeutic yoga worksite stress reduction program
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Mindfulness-based program
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (only assessment)
Number of subjects: 239
Study: 19642717

Group type: EXPERIMENTAL
Intervention: 5% lidocaine for 2 minutes
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5% lidocaine for 5 minutes
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5% lidocaine for 10 minutes
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5% lidocaine for 10 minutes (injection of local anesthetic)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 17432074

Group type: EXPERIMENTAL
Intervention: Nasal packing for 24 hours
Number of subjects: 75

Group type: COMPARATOR
Intervention: Nasal packing for 48 hours
Number of subjects: 75
Study: 16322150

Group type: EXPERIMENTAL
Intervention: Preprinted, formatted order sheets
Number of subjects: 2058

Group type: COMPARATOR
Intervention: Regular blank order sheets
Number of subjects: 2058
Study: 12504396

Group type: EXPERIMENTAL
Intervention: Ultrasonographic hip examination
Number of subjects: 629

Group type: COMPARATOR
Intervention: Clinical assessment alone
Number of subjects: 629
Study: 9799060

Group type: EXPERIMENTAL
Intervention: Omeprazole treatment (20 mg for 4 days) with enteric-coated sodium salicylate tablets
Number of subjects: 8

Group type: COMPARATOR
Intervention: Uncoated acetylsalicylic acid tablets
Number of subjects: 8
Study: 10517036

Group type: EXPERIMENTAL
Intervention: Massage therapy (20-minute sessions of shoulder, neck, head, and facial massage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 1677121

Group type: EXPERIMENTAL
Intervention: Anal continence plug (optimum design)
Number of subjects: 10
Study: 6347117

Group type: EXPERIMENTAL
Intervention: Abrupt withdrawal (group A)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Gradual withdrawal (group G)
Number of subjects: 119
Study: 30787651

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching with No Load (DSNL)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching with Light Load (DSLL)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching with Heavy Load (DSHL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Static Stretching (SS)
Number of subjects: 16
Study: 29961640

Group type: EXPERIMENTAL
Intervention: Adalimumab (continuation)
Number of subjects: 673

Group type: COMPARATOR
Intervention: Placebo (withdrawal)
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Adalimumab (any time)
Number of subjects: 673

Group type: COMPARATOR
Intervention: Adalimumab vs Placebo
Number of subjects: 673
Study: 25737375

Group type: EXPERIMENTAL
Intervention: Gentamicin-containing collagen sponges (2 sponges added perioperatively)
Number of subjects: 739

Group type: COMPARATOR
Intervention: Intravenous antimicrobial prophylaxis alone (control)
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Gentamicin-containing collagen sponges
Number of subjects: 739
Study: 23683734

Group type: EXPERIMENTAL
Intervention: Drug-eluting stent (DES)
Number of subjects: 623

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 623
Study: 21948051

Group type: EXPERIMENTAL
Intervention: Retrograde titanium elastic nail fixation (RTEN)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Reconstruction plate fixation (plate group)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both techniques (RTEN and plating)
Number of subjects: 38
Study: 18996069

Group type: EXPERIMENTAL
Intervention: High-caloric food cue exposure
Number of subjects: 77

Group type: COMPARATOR
Intervention: Low-caloric food cue exposure
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Food cue exposure
Number of subjects: 77
Study: 17039321

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylates (5-ASA)
Number of subjects: 34
Study: 15273854

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Haloperidol (5 mg)
Number of subjects: 29
Study: 11145818

Group type: EXPERIMENTAL
Intervention: Provocative discography in asymptomatic group (20 patients)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Provocative discography in symptomatic group with normal psychometric scores (7 patients)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Provocative discography in symptomatic group with abnormal psychometric scores (20 patients)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Provocative discography in discs not treated with surgery in asymptomatic group (20 patients)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Provocative discography in discs not treated with surgery in symptomatic group with normal psychometric testing (7 patients)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Provocative discography in discs not treated with surgery in symptomatic group with abnormal psychometric testing (13 patients)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (symptomatic patients)
Number of subjects: 47
Study: 8976470

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 0
Study: 1633070

Group type: EXPERIMENTAL
Intervention: Fluconazole 400 mg daily
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ketoconazole 200 mg twice daily
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 9
Study: 6428911

Group type: EXPERIMENTAL
Intervention: Ouabain 0.5 mg i.v.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nitroglycerin 0.8 mg sublingual
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ouabain 12 mg sublingual
Number of subjects: 18
Study: 31542806

Group type: EXPERIMENTAL
Intervention: 840 mg every 2 weeks (q2w)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1680 mg every 4 weeks (q4w)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1200 mg every 3 weeks (q3w)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maximum assessed dose (MAD; 20 mg/kg q3w)
Number of subjects: 0
Study: 30532195

Group type: EXPERIMENTAL
Intervention: NMES on tibialis anterior muscle (NMES-TA)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: NMES on medial gastrocnemius muscle (NMES-MG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (range of motion and stretching exercises)
Number of subjects: 25
Study: 27845159

Group type: EXPERIMENTAL
Intervention: Tobacco Heating System (THS) 2.2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous use of non-menthol combustible cigarettes (CC arm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking abstinence (SA arm)
Number of subjects: 0
Study: 24568910

Group type: EXPERIMENTAL
Intervention: Conventional treatment
Number of subjects: 214

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 214
Study: 21335358

Group type: EXPERIMENTAL
Intervention: 25 mg of MK-0249 (H3RIA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Stable alcohol level (0.6 g L(‐1))
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20374986

Group type: EXPERIMENTAL
Intervention: Online multifamily group program for relatives of persons with schizophrenia
Number of subjects: 26

Group type: COMPARATOR
Intervention: Customary care
Number of subjects: 26
Study: 18057478

Group type: EXPERIMENTAL
Intervention: Full dose candy (vitamin A 1000 IU and 14 mg elemental iron) daily
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Full dose candy for 3 days a week
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Half dose candy (vitamin A 500 IU and 7 mg elemental iron) daily
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study: 16327947

Group type: EXPERIMENTAL
Intervention: DHEP alone (Flector Tissugel)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DHEP/heparin (Flector Tissugel Heparin)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12139912

Group type: EXPERIMENTAL
Intervention: Midwife examination
Number of subjects: 826

Group type: COMPARATOR
Intervention: Junior paediatrician examination
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Discussion of health-care issues during examination
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Current maternal depressive mood
Number of subjects: 826
Study: 9829113

Group type: EXPERIMENTAL
Intervention: Translucent (frosted) diffuser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: +1.50 D (fogging) lens
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: White opaque occluder
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Binocular summation ratios
Number of subjects: 20
Study: 9809958

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 2% dodecafluoropentane emulsion (EchoGen)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No contrast (baseline assessment)
Number of subjects: 40
Study: 2535086

Group type: EXPERIMENTAL
Intervention: Continuous epidural analgesia with bupivacaine 0.125% and sufentanil 0.83 micrograms.ml‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous peroperative and on-demand intramuscular postoperative analgesia with nicomorphine 0.2 mg.kg‐1
Number of subjects: 20
Study: 341650

Group type: EXPERIMENTAL
Intervention: Viloxazine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 30
Study: 31407810

Group type: EXPERIMENTAL
Intervention: Subcutaneous Nexvax2 (900 µg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intravenous Nexvax2 (900 µg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 28918556

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 26298520

Group type: EXPERIMENTAL
Intervention: 1 hour of simulation training
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 17
Study: 23526949

Group type: EXPERIMENTAL
Intervention: ChAd63-MVA ME-TRAP
Number of subjects: 46
Study: 21471773

Group type: EXPERIMENTAL
Intervention: Sildenafil (initial dose of 50 mg, adjustable to 25 or 100 mg)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 202
Study: 19011931

Group type: EXPERIMENTAL
Intervention: Selective pharmacological inhibition of the norepinephrine transporter (NET)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 16158312

Group type: EXPERIMENTAL
Intervention: Oral topotecan (1.2 mg/m2) once a day for 10 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oral topotecan (1.2 mg/m2) twice a day for 5 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Twice a day dosing of topotecan
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Once a day dosing of topotecan
Number of subjects: 90
Study: 15309247

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optional regimens for low-risk and high-risk patients
Number of subjects: 0
Study: 11281598

Group type: EXPERIMENTAL
Intervention: Hughes tarsoconjunctival advancement combined with oblique medial and lateral periosteal flaps
Number of subjects: 8
Study: 9394980

Group type: EXPERIMENTAL
Intervention: Acidic hot-spring bathing (10-min bath at 42 degrees C, twice daily)
Number of subjects: 70
Study: 8071832

Group type: EXPERIMENTAL
Intervention: Ceftibuten (400 mg every 12 h for 8 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftibuten metabolite (trans-isomer)
Number of subjects: 0
Study: 3310745

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 22
Study: 29288545

Group type: EXPERIMENTAL
Intervention: Lorcaserin (10 mg twice a day)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Lorcaserin and Placebo
Number of subjects: 137
Study: 26987876

Group type: EXPERIMENTAL
Intervention: 9-week multi-component intervention including the Sapere method, cooked lunches, meal principles, and parental involvement.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group continued usual practices.
Number of subjects: 18
Study: 25718355

Group type: EXPERIMENTAL
Intervention: 24-month dual-antiplatelet therapy (DAPT) in ACS patients
Number of subjects: 1970

Group type: COMPARATOR
Intervention: 6-month dual-antiplatelet therapy (DAPT) in ACS patients
Number of subjects: 1970

Group type: EXPERIMENTAL
Intervention: 24-month dual-antiplatelet therapy (DAPT) in SCAD patients
Number of subjects: 1970

Group type: COMPARATOR
Intervention: 6-month dual-antiplatelet therapy (DAPT) in SCAD patients
Number of subjects: 1970
Study: 22323747

Group type: EXPERIMENTAL
Intervention: varenicline (1 mg twice daily for 4 weeks after 4 weeks of titration)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 20528570

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones (rosiglitazone and pioglitazone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral contraceptives
Number of subjects: 0